Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$7.87M Buy
128,662
+109,746
+580% +$6.68M 0.22% 31
2017
Q1
$1.15M Sell
18,916
-109,605
-85% -$6.65M 0.03% 612
2016
Q4
$7.22M Buy
128,521
+92,815
+260% +$5.43M 0.18% 41
2016
Q3
$2.13M Sell
35,706
-5,850
-14% -$342K 0.05% 281
2016
Q2
$2.28M Sell
41,556
-36,432
-47% -$1.94M 0.05% 281
2016
Q1
$3.94M Buy
77,988
+69,532
+822% +$3.41M 0.11% 97
2015
Q4
$426K Sell
8,456
-8,284
-49% -$418K 0.01% 1735
2015
Q3
$789K Sell
16,740
-34,310
-67% -$1.82M 0.01% 1088
2015
Q2
$2.77M Buy
51,050
+20,906
+69% +$1.17M 0.05% 314
2015
Q1
$1.65M Sell
30,144
-4,139
-12% -$234K 0.03% 472
2014
Q4
$1.86M Sell
34,283
-52,425
-60% -$2.92M 0.03% 471
2014
Q3
$4.91M Sell
86,708
-47,750
-36% -$2.68M 0.09% 148
2014
Q2
$7.42M Buy
+134,458
New +$7.34M 0.12% 102
2014
Q1
Sell
-49,675
Closed -$2.57M 3859
2013
Q4
$2.37M Buy
49,675
+28,656
+136% +$1.31M 0.03% 547
2013
Q3
$955K Buy
+21,019
New +$960K 0.01% 1213

Other funds holding MRK

Virtu KCG Holdings's MRK Position: Q2 2017 in Review

Virtu KCG Holdings increased its Merck (MRK) stake by 580% in Q2 2017, buying an estimated $6.68M and bringing the position to 128,662 shares worth $7.87M. The position accounts for 0.22% of the portfolio, ranked #31.

Virtu KCG Holdings first reported a position in MRK in Q3 2013 and has held it in 15 quarters since. 1,925 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

  • Virtu KCG Holdings held 128,662 shares of Merck worth $7.87M as of Q2 2017.
  • Virtu KCG Holdings bought 109,746 Merck shares in Q2 2017, an estimated $6.68M.
  • Merck made up 0.22% of Virtu KCG Holdings's portfolio in Q2 2017, its #31 holding.
  • Virtu KCG Holdings first reported a position in Merck in Q3 2013 and has held it in 15 quarters since.
  • 1,925 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.